Andrzej Jakubowiak to Anemia
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Anemia.
Connection Strength
0.317
-
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nat Med. 2023 10; 29(10):2570-2576.
Score: 0.217
-
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. Blood. 2012 Aug 30; 120(9):1801-9.
Score: 0.099